Companies: 10,795·Total market cap: $144.5T
Sanofi

Sanofi

SNYNASDAQHealthcare● Active
$44.05
$-0.97(-2.15%)
Market Cap$106.1B
P/E Ratio
52W High$52.68
52W Low$42.28

Sanofi (SNY) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

sny · stock forecast · 27 analysts (3M) · FMP · updated Jun 8, 2026

Analyst Rating & Consensus

Based on 27 Wall Street analysts in the past 3 months

SellBuy

Buy

27 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
14
Hold
11
Sell
2
Strong Sell
0
Total: 27 · Buy rate: 51.9%

12-Month Price Target

High

$52.00

Consensus

$51.00

+15.8% upside

Low

$50.00

Median: $51 · Last Close: $44.06

The Sanofi (SNY) analyst consensus is Buy, based on ratings from 27 Wall Street analysts over the past 3 months. The average 12-month SNY price target is $51.00, representing +15.8% upside from the current price of $44.06.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $51 (15.8%)

Consensus Target

$51.00

15.8% upside

High Target

$52

18.0%

Low Target

$50

13.5%

Current Price

$44.06

as of today

Based on analyst price targets, the SNY stock price prediction for the next 12 months ranges from $50 to $52. The consensus SNY price forecast of $51.00 implies 15.8% upside from the current price of $44.06.

Short-Term Price Prediction

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$44.120.13%

1-day model range: $43.97–$44.26. Peak: $44.26 (+0.13%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$47+5.7%
2028$48+9.6%
2029$49+12.2%
2030$50+14.0%
2031+15.2%
Confidence:Medium

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

NEUTRAL

Based on 14 technical indicators

43%7%50%
6Buy
1Neutral
7Sell
RSI (14)53.2Neutral
MACDBEARISH

Refreshes daily from EOD close

Moving Averages · SNY · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$43.73BUY
MA 10$43.81BUY
MA 20$43.62BUY
MA 50$45.35SELL
MA 100$45.86SELL
MA 200$47.41SELL
Current $SNY · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$44.02BUY
EMA 10$43.89BUY
EMA 20$44.00BUY
EMA 50$44.79SELL
EMA 100$45.76SELL
EMA 200$47.06SELL
Current $SNY · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
UBS2026-01-16
Downgrade ↓
BuyNeutral
Barclays2026-01-06
Downgrade ↓
OverweightEqual Weight
Guggenheim2025-12-09
Downgrade ↓
BuyNeutral
JP Morgan2025-12-08
Downgrade ↓
OverweightNeutral
Morgan Stanley2025-09-08
Upgrade ↑
Equal WeightOverweight
Deutsche Bank2025-09-02
Upgrade ↑
HoldBuy
JP Morgan2025-08-08
Upgrade ↑
NeutralOverweight
Argus Research2024-07-26
Maintains
BuyBuy
Argus Research2023-03-27
Maintains
BuyBuy
Deutsche Bank2022-08-12
Upgrade ↑
SellHold

Wall Street analysts have recently issued updated ratings on Sanofi (SNY) stock. Of the recent 55 rating actions, 22 were upgrades and 26 were downgrades. 27 analysts currently cover SNY.

Analyst Recommendation Trends

Buy ratings101
Hold ratings02↑ +2
Sell ratings00

SNY analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 0 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$48.0B

↓ 10.2% YoY

Revenue Next Year

$51.0B

↑ 6.1% YoY

EPS This Year

$4.21

EPS Next Year

$4.49

↑ 6.7% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast SNY EPS of $4.21 for the current fiscal year, based on estimates from 7 analysts. The SNY revenue forecast is $48.0B for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The SNY stock forecast is supported by two independent data sources: analyst consensus ratings from 27 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus SNY price target is $51.00 (+15.8% upside), with an analyst consensus of Buy.

The SNY short-term stock prediction for tomorrow is $44.12 (+0.13%). The SNY stock price prediction for 2027 estimates an average of $47. The SNY stock prediction for 2030 projects a range of $48–$52.

Sanofi trades on NASDAQ under the ticker SNY. The SNY stock outlook for 2027 is broadly positive, supported by a Buy consensus among 52% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

SNY forecast · 8 questions

According to 27 Wall Street analysts, the average 12-month SNY price target is $51.00, with a high forecast of $52.00 and a low of $50.00. The median price target is shown in the chart above when available. This implies +15.8% potential upside from the current price of $44.06.

SNY price targetWhat is SNY price targetSNY analyst price targetSNY 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.